Dmytro Dmytriiev

Prof. Dr. Dmytro Dmytriiev

orcid

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 April 2018 in Pediatric Anesthesia
Verified
Journal Article
Open access
PDF file
MVMaria Vittinghoff
Maria Vittinghoff
PLPer‐Arne Lönnqvist
Per‐Arne Lönnqvist
VMValeria Mossetti
Valeria Mossetti
SHStefan Heschl
Stefan Heschl
DSDusica Simic
Dusica Simic
NMNeil S. Morton
Neil S. Morton
Summary: The main remit of the European Society for Paediatric Anaesthesiology (ESPA) Pain Committee is to improve the quality of pain management in children. The ESPA Pain Management Ladder is a clinical practice advisory based upon expert consensus to help to ensure a basic standard of perioperative pain management for all children. Further steps are suggested to improve pain management once a basic standard has been achieved. The guidance is grouped by the type of surgical procedure and layered to suggest basic, intermediate, and advanced pain management methods. The committee members are aware that there are marked differences in financial and personal resources in different institutions and countries and also considerable variations in the availability of analgesic drugs across Europe. We recommend that the guidance should be used as a framework to guide best practice.

22 February 2022 in Regional Anesthesia & Pain Medicine
Verified
Journal Article
Open access
PDF file
Hassan MohamedHassan Mohamed
Hassan Mohamed
BABenjamin P Atterton
Benjamin P Atterton
GCGillian G Crowe
Gillian G Crowe
JBJaime L Barratta
Jaime L Barratta
MJMark Johnson
Mark Johnson
EME M Louise Moran
E M Louise Moran
Background and objectives Documentation is important for quality improvement, education, and research. There is currently a lack of recommendations regarding key aspects of documentation in regional anesthesia. The aim of this study was to establish recommendations for documentation in regional anesthesia. Methods Following the formation of the executive committee and a directed literature review, a long list of potential documentation components was created. A modified Delphi process was then employed to achieve consensus amongst a group of international experts in regional anesthesia. This consisted of 2 rounds of anonymous electronic voting and a final virtual round table discussion with live polling on items not yet excluded or accepted from previous rounds. Progression or exclusion of potential components through the rounds was based on the achievement of strong consensus. Strong consensus was defined as ≥75% agreement and weak consensus as 50%–74% agreement. Results Seventy-seven collaborators participated in both rounds 1 and 2, while 50 collaborators took part in round 3. In total, experts voted on 83 items and achieved a strong consensus on 51 items, weak consensus on 3 and rejected 29. Conclusion By means of a modified Delphi process, we have established expert consensus on documentation in regional anesthesia.

14 March 2022
Verified
Journal Article
Open access
ONOleksandr Nazarchuk
Oleksandr Nazarchuk
DDDmytro Dmytriiev
Dmytro Dmytriiev
YBYuliana Babina
Yuliana Babina
MFMariia Faustova
Mariia Faustova
VBVita Burkot
Vita Burkot
About 60% of all nosocomial infections are caused by microorganisms found in biofilms. Acinetobacter baumannii, as a pathogen of nosocomial infections, occur more frequently in surgical hospitals. The aim of the study was to study the in vitro formation of A. baumannii monotype biofilms under the influence of local anesthetics and antiseptics Materials and methods. The antimicrobial activity of local anesthetics (0.25-0.5%, bupivacaine, 2.0% lidocaine, 0.75% ropivacaine) and antiseptics (decamethoxine 0.1%, octenidine 0.1%, chlorhexidine 0.05%) ) against clinical strains of A. baumannii and studied their ability to produce biofilms. The bacteriostatic effect of local anesthetics on A. baumannii within the current concentrations of these drugs, which provide analgesic effect, has been proven. The given results indicate that A.baumanni cultures have a pronounced ability to form biofilms. Clinical strains of opportunistic microorganisms A. baumannii circulating in the hospital environment are highly sensitive to antiseptics decamethoxine and octenidine, chlorhexidine has a weak bactericidal effect against acinetobacteria. The results of studying the effect of local anesthetics on the process of formation of the strain "young" biofilms showed the presence of a dose-dependent effect. The greatest inhibitory activity against "young" biofilms was detected under the combined action of the antiseptic decamethoxine (in concentrations, not exceeding 3.9 μg / ml) and anesthetics (OD-0,199-0,223) (p <0,05). Scientific research on various aspects of the formation (or destruction) of bacterial biofilms is a relevant and promising area that will change approaches to the prophylaxis and treatment of a number of infections, including postoperative infectious complications.

10 August 2021 in Anaesthesia, Pain & Intensive Care
Verified
Journal Article
Open access
PDF file
DDDmytro Dmytriiev
Dmytro Dmytriiev
ODOleksandr Dobrovanov
Oleksandr Dobrovanov
The COVID-19 pandemic has affected the lives and health of people all around the world. Although majority of patients with COVID-19 experience respiratory symptoms, pain is also a very important symptom. The condition of 15-20% of patients is serious and requires hospitalization. Despite the fact that the disease was initially referred to as a respiratory disease, it often affects other systems as well; the most common are the cardiovascular, urologic and nervous system. Multi-organ involvement increases the need for intensive care and treatment of several consequences caused by the disease. Due to severity of the disease, the management of complications following release from hospital should also be considered. The provision of multidisciplinary care that supports both physical and mental recovery in the initial stages of hospitalization can minimize the damage. Cognitive, physical and mental dysfunction reported by COVID-19 patients after discharge may have significant impact on the quality of human life. Pain is usually part of the dysfunction. The post-COVID-19 pain syndrome is still not completely understood, in particular the way it affects patients after they have recovered from COVID-19. There is limited information on the clinical characteristics, treatment, results and pain management in COVID-19 patients. The aim of our article is to provide an overview of the impact COVID-19 has on conditions associated with acute and chronic pain. Key words: Acute pain; Chronic pain; Co-morbidity; Pain syndrome; Pandemic COVID-19; SARS-CoV-2 Citation: Dmytriiev D, Dobrovanov O, Post-COVID pain syndrome. Anaesth. pain intensive care 2021;25(4):505–512. DOI: 10.35975/apic.v25i4.1582


24 April 2023
Verified
Journal Article
Open access
BLBohdan Levchenko
Bohdan Levchenko
ONOleksandr Nazarchuk
Oleksandr Nazarchuk
DDDmytro Dmytriiev
Dmytro Dmytriiev
NBNatalia Bahniuk
Natalia Bahniuk
MMMykola Melnychenko
Mykola Melnychenko
KDKostiantyn Dmytriiev
Kostiantyn Dmytriiev
VAP remains the second leading cause of death among the patients with nosocomial infections and its incidence varies significantly from 5% to 60% reaching on average 10%. It is of crucial importance to develop novel treatment approaches and optimize the existing ones. Thus, the aim of this pilot study was to study the laboratory-microbiological effect of inhaled aminoglycosides in a complex treatment of patients with ventilator-associated pneumonia (VAP). To study the laboratory-microbiological effect of adjunctive inhaled aminoglycosides in the treatment of VAP, twenty enrolled patients were randomly subdivided into 2 groups (n=10). Amikacin was administered via a nebulizer starting from the first day of VAP manifestation. Inhalations were performed BID for 7 days via a nebulizer integrated into the breathing circuit. We assessed: cell membrane alterations in leukocytes, Annexin V/7-AAD staining for leukocytes, ROS detection assay for leukocytes. Adjunctive administration of inhaled amikacin reduced the fluorescence intensity ratio more efficiently compared with the intravenous antimicrobial treatment with no aerosolized amikacin following both 48 h and 96 h of treatment. The amount of dead necrotic annexin V-negative, 7-AAD-positive leukocytes was significantly lower under the use of inhaled amikacin than at the beginning of treatment. In this pilot study, we found that administration of aerosolized amikacin combined with the systemic antimicrobial therapy improves the clinical outcome of patients with VAP, effective early microbial decrease in the sputum, reduces reactive oxygen species generation in leukocytes and the degree of leukocyte apoptosis and necrosis, decreases VAP-mediated cell membrane alterations of circulating leukocytes.